Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Lion Finance unveils share buyback as 2024 profits surge

(Sharecast News) - Shares in Lion Finance Group surged on Tuesday after the Georgian bank lifted its dividend and extended its share buyback programme following strong results for 2024, in which profits surged. The company this month changed it name from Bank of Georgia Group to better reflect its broader geographical presence following its acquisition of Armenia's largest bank, Ameriabank, in 2024.

Adjusted profits totalled GEL1.81bn (£0.5bn) in 2024, up 31.9% on the year before, with operating income jumping 40.8% to GEL3.56bn.

The loan book increased 65.9% year-on=year to GEL33.56bn, driven by strong growth in both Georgian and Armenian business, as well as the consolidation effect of Ameriabank.

The board declared a final dividend of GEL5.62 per share, bringing the total payout to GEL9.00, up 12.5% on 2023's payout.

In addition, the board approved a further GEL107.7m share buyback plan, bringing its overall payout ratio to 31% for 2024.

"Moving into 2025, we remain focused on driving strong customer franchise growth and high profitability across our main markets," said chief executive Archil Gachechiladze.

Shares were up 8.7% at 5,770p by 0840 GMT.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.